This announcement informs us of continued support for MVP existing business and continued function of the business under the COVID19 epidemic conditions. It does not discuss the enormous potential for the Continuous Flow Technology to fulfil the huge demands for drugs used to manage the COVID19 illness. Hospitals are running out of drugs. There needs to be a huge increase in production capacity to meet current needs.
Ann: COVID-19 Impact on MVP, page-43
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
